In June, the American Society of Anesthesiologists reported anecdotal evidence of GLP-1s resulting in regurgitation and aspiration in surgeries. The drugs delay gastric emptying, meaning normal fasting rules weren’t enough for normal preoperative strategies, so the ASA recommended patients miss a dose. The American Association of Nurse Anesthesiology published a similar guidance in March.
Other experts acknowledged seeing similar anecdotal evidence but said the guidelines were an overreaction and created more issues. The American Gastroenterological Association called the issue a “clinical dilemma,” adding that too many surgeries were canceled due to a perceived risk.
In a study published April 22 in JAMA, Stanford Medicine researchers evaluated more than 23,000 patient records to investigate the surgical risks associated with GLP-1 use.
They found none.
“Overall incidence of postoperative respiratory complications was 3.5% for those with a GLP-1 RA fill and 4% for those without,” they wrote. “Results of this study suggest that liberalizing the withholding guidelines for GLP-1 RAs preoperatively should be considered.”
At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.